What is Vytrus Biotech?
Vytrus Biotech is a pioneering company specializing in the development and production of plant-based active ingredients for the cosmetics industry. Leveraging advanced biotechnological processes, the company creates high-value natural actives for skin and hair care applications, including flagship products like Clarivine and Baolift. Vytrus Biotech's commitment to sustainability and minimal environmental impact positions it as a key innovator, targeting cosmetic manufacturers and formulators seeking quality and efficacy derived from nature.
How much funding has Vytrus Biotech raised?
Vytrus Biotech has raised a total of $2.6M across 2 funding rounds:
Angel/Seed
$708K
Unspecified
$1.9M
Angel/Seed (2017): $708K, investors not publicly disclosed
Unspecified (2020): $1.9M, investors not publicly disclosed
What's next for Vytrus Biotech?
The recent major strategic investment signals a pivotal phase for Vytrus Biotech, likely enabling the company to scale its operations, enhance its research and development capabilities, and expand its market reach. This substantial backing suggests a strong investor confidence in Vytrus Biotech's innovative approach to plant biotechnology and its potential to capture a larger share of the growing natural cosmetics market. Future endeavors may include further product line diversification and strategic partnerships to solidify its leadership in sustainable ingredient solutions.
See full Vytrus Biotech company page
